A3P

Log in

AstraZeneca and Takeda team up against Parkinson's disease

The British pharmaceutical group AstraZeneca announced Tuesday an alliance with its Japanese counterpart Takeda to develop a potential treatment against Parkinson's disease.

Read more...

With Kite Pharma, Gilead enters immuno-oncology through the large door

US pharmaceutical group Gilead made a major step towards diversification by announcing on Monday the acquisition of 11,9 billion of its compatriot Kite Pharma, one of the world leaders of a very promising cancer immunotherapy.

Read more...

Cosmetics: European regulation is the most rigorous in the world

The French cosmetics industry stresses on Thursday that the European regulation is "the most rigorous in the world" and that it "applies to all the products, whatever the user for whom they are intended".

Read more...

More 420 tons of contraband drugs seized in West Africa

Interpol announced Friday the seizure of more than 420 tons of contraband medical products in West Africa, as part of a vast international police operation.

Read more...

Roche: priority review in the United States on treatment for hemophilia

Swiss pharmaceutical company Roche said on Thursday that US health authorities have granted priority status to its new treatment for hemophilia.

Read more...

a3p-100pxhaut logo

 fren

Commit to share
Transmit and progress together
Promoting innovation

The A3P Association is a major player in the pharmaceutical and biotechnology industry.
Created in 1986, it contributes to the good development of the production of medicines and clean and sterile equipment, it runs a network of professionals 21 000, manufacturers and suppliers, as part of International Congress and technical days.

It now has over 1700 members who share their technical experience, scientific and regulatory.

More info on video (Versiongb here )


  group    administrators A3P
    
& Project Managers

letter   newsletter A3P